審稿專家
孫紅| 廣州醫科大學附屬第一醫院婦産科副主任醫師
參考文獻
[1]Ji N, Liu SW, Zeng XY, Dong WL, Jiang YY, Zhou MG. [Disease burden for gynecological disease in China, 2016]. Zhonghua Fu Chan Ke Za Zhi. 2018 May 25;53(5):313-318. Chinese. doi: 10.3760/cma.j.issn.0529-567x.2018.05.006. PMID: 29804349.
[2]沈铿, 崔恒, 豐有吉. 常見婦科惡性惡性良性腫瘤診治指南[J]. 人民衛生出版社, 2014.
[3]中國抗癌協會婦科惡性良性腫瘤專業委員會. 子宮頸癌診斷與治療指南(2021年版)[J]. 中國癌症雜志 2021年31卷6期, 474-489頁, ISTIC PKU CSCD CA, 2021.
[4]羅漫靈, 胡海燕, 鐘梅. 2017年USPSTF建議聲明:通過骨盆檢查進行婦産科疾病篩查指南[J]. 婦産與遺傳(電子版), 2017(3).
[5]原著Peter W. Callen. 婦産科超聲學[M]. 人民衛生出版社, 2010.
[6]Sawaya GF, Smith-McCune KK, Gregorich SE, Moghadassi M, Kuppermann M. Effect of professional society recommendations on women's desire for a routine pelvic examination. Am J Obstet Gynecol. 2017 Sep;217(3):338.e1-338.e7. doi: 10.1016/j.ajog.2017.05.003. Epub 2017 May 18. PMID: 28528899; PMCID: PMC6434937.
[7]ACOG Committee Opinion No. 754: The Utility of and Indications for Routine Pelvic Examination. Obstet Gynecol. 2018 Oct;132(4):e174-e180. doi: 10.1097/AOG.0000000000002895. PMID: 30247363.
[8]Sarah Feldman. 宮頸癌篩查. UpToDate 2021.
内容制作